NO941191L - Partikler, fremgangsmåte for fremstilling samt anvendelse av slike - Google Patents

Partikler, fremgangsmåte for fremstilling samt anvendelse av slike

Info

Publication number
NO941191L
NO941191L NO941191A NO941191A NO941191L NO 941191 L NO941191 L NO 941191L NO 941191 A NO941191 A NO 941191A NO 941191 A NO941191 A NO 941191A NO 941191 L NO941191 L NO 941191L
Authority
NO
Norway
Prior art keywords
phase
particles
homogeneous
lamellar
delivery system
Prior art date
Application number
NO941191A
Other languages
English (en)
Norwegian (no)
Other versions
NO941191D0 (no
Inventor
Tomas Landh
Kaare Larsson
Original Assignee
Gs Biochem Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Biochem Ab filed Critical Gs Biochem Ab
Publication of NO941191D0 publication Critical patent/NO941191D0/no
Publication of NO941191L publication Critical patent/NO941191L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO941191A 1991-10-04 1994-03-30 Partikler, fremgangsmåte for fremstilling samt anvendelse av slike NO941191L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77101491A 1991-10-04 1991-10-04
PCT/SE1992/000692 WO1993006921A1 (fr) 1991-10-04 1992-10-02 Particules, procede de preparation desdites particules et utilisations

Publications (2)

Publication Number Publication Date
NO941191D0 NO941191D0 (no) 1994-03-30
NO941191L true NO941191L (no) 1994-06-01

Family

ID=26661355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941191A NO941191L (no) 1991-10-04 1994-03-30 Partikler, fremgangsmåte for fremstilling samt anvendelse av slike

Country Status (2)

Country Link
NO (1) NO941191L (fr)
WO (1) WO1993006921A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183099T1 (de) * 1991-04-19 1999-08-15 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
JPH09510182A (ja) * 1993-11-17 1997-10-14 エルディーエス・テクノロジーズ・インコーポレーテッド カプセル封入されたドラッグデリバリー用透明液
FR2720937B1 (fr) 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
SE9602280D0 (sv) * 1996-06-10 1996-06-10 Pharmatrix Ab Immunstimulerande lipidformulering
WO1997047250A1 (fr) * 1996-06-13 1997-12-18 Mehl Thomas L Sr Cristaux liquides utilises dans des traitements dermatologiques par energie lumineuse
US6306433B1 (en) 1997-08-12 2001-10-23 Pharmacia Ab Method of preparing pharmaceutical compositions
DE69816778T2 (de) 1997-09-09 2004-04-15 Lyotropic Therapeutics, Inc. Beschichtete teilchen, methode zu ihrer herstellung und verwendung
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
EP0948902A1 (fr) * 1998-03-13 1999-10-13 Societe Des Produits Nestle S.A. Composition alimentaire contenant une phase mésomorphe de monoglycéride
SE9900495D0 (sv) * 1999-02-12 1999-02-12 Pharmatrix Ab Vaccine composition
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
SE527505C2 (sv) * 2003-06-10 2006-03-28 Anna Imberg Komposita material och partiklar
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
FR2861988B1 (fr) * 2003-11-07 2006-01-06 Oreal Utilisation cosmetique de particules de gel cubique en tant qu'agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
ES2383530T3 (es) * 2004-08-04 2012-06-22 Camurus Ab Composiciones que forman dispersiones no laminares
PL1843746T3 (pl) * 2005-01-14 2011-09-30 Camurus Ab Formulacje analogów somatostatyny
DE602005020359D1 (de) 2005-01-14 2010-05-12 Camurus Ab Topische bioadhäsive formulierungen
DE602005026998D1 (de) 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
EP1843751B1 (fr) 2005-01-21 2020-09-30 Camurus Ab Compositions lipidiques pharmaceutiques
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
WO2006131730A1 (fr) 2005-06-06 2006-12-14 Camurus Ab Formulations d'analogues de glp-1
RU2008125118A (ru) * 2005-11-23 2009-12-27 Нестек С.А (Ch) Эмульсия масло-в-воде для придания продукту новой консистенции
WO2007147002A2 (fr) * 2006-06-13 2007-12-21 Wisconsin Alumni Research Foundation Cristaux liquides lyotropes de peptide bêta et leurs procédés de fabrication et d'utilisation
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US11672843B2 (en) 2012-05-25 2023-06-13 Camurus Ab Somatostatin receptor agonist formulations
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA3078723A1 (fr) 2016-11-28 2018-05-31 Nachiappan Chidambaram Traitement oral a base d'undecanoate de testosterone
SE541313C2 (en) * 2017-10-13 2019-06-25 Amferia Ab Amphiphilic antimicrobial hydrogel
WO2021215952A1 (fr) 2020-04-24 2021-10-28 Общество С Ограниченной Ответственностью "Индженик" Procédé de production de particules de bactériophages de la famille levivirus
WO2023225722A1 (fr) * 2022-05-26 2023-11-30 Royal Melbourne Institute Of Technology Vaccin à nanovecteur lipidique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4556289A (en) * 1983-03-21 1985-12-03 Manchester R & D Partnership Low birefringence encapsulated liquid crystal and optical shutter using same
GB8803037D0 (en) * 1988-02-10 1988-03-09 Unilever Plc Aqueous detergent compositions & methods of forming them
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals

Also Published As

Publication number Publication date
WO1993006921A1 (fr) 1993-04-15
NO941191D0 (no) 1994-03-30

Similar Documents

Publication Publication Date Title
NO941191L (no) Partikler, fremgangsmåte for fremstilling samt anvendelse av slike
FI941538A (fi) Partikkelit, menetelmä niiden valmistamiseksi ja niiden käyttö
NO20002409L (no) FremgangsmÕte for Õ produsere arsen trioksyd formuleringer og metoder for Õ behandle cancer ved Õ bruke arsen trioksyd eller melarsoprol
Kimberlin et al. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection
Light et al. Pleural sclerosis for the treatment of pneumothorax and pleural effusion
AR024008A1 (es) Uso de microesferas biodegradables que liberan un agente anticancerigeno, para el tratamiento de glioblastoma, proceso para la preparacion de estasmicroesferas y suspension que contiene a las mismas
EP0355307A3 (fr) Moyens d'extraction de l'acide poly-D(-)-3-hydroxy butyrique
CA2122612A1 (fr) Produits pharmaceutiques antitumoraux et methode de preparation
ES2163504T3 (es) Formas de dosificacion de liberacion controlada de azitromicina.
ES2125887T3 (es) Procedimiento ortomolecular para tratar la anemia drepanocitica.
Pochon et al. 4-Thiouridine and the conformation of E., coli tRNA induced by spermidine
US20010043951A1 (en) Polyphosphate for use in promoting wound healing and scar abatement
Landyshev et al. Efficacy of low intensity laser irradiation and sodium nedocromil in the complex treatment of patients with bronchial asthma
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MY114241A (en) Combination of atovaquone with proguanil for the treatment of protozoal infections
NO307933B1 (no) Vann-uløselig eller lite vannløselig terapeutisk forbindelse, anvendelse derav samt farmasøytisk blanding inneholdende nevnte forbindelse
Leung et al. Total skin electron beam irradiation in scleromyxoedema.
FR2457691A1 (fr) Association homeopathique anti-infectieuse de glycerophosphate de magnesium, triodure de phosphore et nitrate d'uranyle
Majchrowicz Kombucha: a dubious" cure"
RU2690945C2 (ru) Способ лечения кожных заболеваний, ожогов, поверхностных и глубоких ран
Morgan et al. Onycholysis in a case of atopic eczema treated with PUVA photochemotherapy
RU2694536C2 (ru) Способ лечения кожных заболеваний, ожогов, поверхностных и глубоких ран
Beckham LECITHIN THERAPY FOR TARDIVE DYSKINESIA.
Menter Occlusion of potent topical steroids
Hirohama et al. EPR study of the dynamic behavior of cis, cis-1, 3, 5-triaminocyclohexane Cu (II) complex on B-form DNA-fibers